Vellora Impact Q1 Results: Net profit jumps to ₹7.9 crore

2 min read     Updated on 01 Aug 2026, 12:15 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Vellora Impact Limited posted a Q1FY27 net profit of ₹7.90 crore on revenue of ₹141.92 crore, driven by its new agriculture segment. The statutory auditor issued a qualified opinion due to non-compliance with Ind AS standards on employee benefits, though management asserts no material adverse impact on going concern status.

powered bylight_fuzz_icon
47112302

*this image is generated using AI for illustrative purposes only.

Vellora Impact Limited reported a net profit of ₹7.90 crore for the quarter ended June 30, 2026, reversing a net loss of ₹2.11 crore in Q1FY26. The company’s revenue from operations jumped to ₹141.92 crore, compared to ₹1.17 crore in the preceding quarter and ₹1.17 crore in the corresponding period last year. This performance reflects the company’s strategic shift from chemical manufacturing to information technology and agriculture services, with management citing a significant revenue-generating contract secured in Q4FY26 as a key driver for future operations.

The Board of Directors approved the unaudited financial results on July 22, 2026, in compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The statutory auditor, Chandabhoy & Jassoobhoy Chartered Accountants, issued a limited review report but included a qualified opinion. The qualification stems from the company accounting for gratuity and leave encashment on a cash basis, which contradicts Ind AS 1 and Ind AS 19 standards prescribed by the Institute of Chartered Accountants of India. The auditor noted that the extent of non-compliance in terms of value is not ascertainable.

Financial Performance Breakdown

The company’s financials show a distinct separation between its discontinued chemical operations and new business segments. Total income stood at ₹141.92 crore, entirely derived from operations, as other income remained negligible at ₹0.00 lakh. Expenses were primarily driven by the purchase of stock-in-trade at ₹135.66 crore, partially offset by a decrease in inventories of ₹1.94 crore.

Particulars Q1FY27 (₹ in lakhs) Q4FY26 (₹ in lakhs) Q1FY26 (₹ in lakhs)
Revenue from Operations 14,192.10 117.94 116.86
Other Income 0.00 11.42 0.05
Total Income 14,192.10 129.36 116.91
Total Expenses 13,401.77 59.69 335.57
Profit Before Tax 790.33 69.66 (218.66)
Net Profit 790.33 21.12 (211.16)

Segment reporting reveals that the agriculture segment contributed ₹141.92 crore to revenue and generated an EBITDA of ₹7.98 crore. In contrast, the chemical segment, which was discontinued during the previous year, had previously contributed ₹1.18 crore in revenue for Q4FY26. The company’s total assets associated with the agriculture segment stand at ₹74.51 crore, matching its liabilities for that segment.

Auditor Qualifications and Business Transition

The qualified opinion also draws attention to the discontinuation of manufacturing operations in September 2025. Machinery and building structures were dismantled, with some sold as scrap and others impaired. However, assets were later sold at values better than expected, leading to a reversal of impairment losses booked in the prior year. From January 1, 2026, the company officially changed its business objective to information and technology services.

Management maintains that the audit qualifications will not have a material adverse impact on future operations or the company’s ability to continue as a going concern. They emphasize that the diversification into new business lines and the securing of significant contracts support this view. The earnings per share for the quarter stood at ₹14.19, a stark improvement from the diluted EPS of ₹(3.79) in Q1FY26.

Historical Stock Returns for Pratiksha Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
-3.51%-29.37%-24.68%-33.21%-27.05%+14.75%

How will the auditor's qualified opinion regarding non-compliance with Ind AS 1 and 19 impact Vellora Impact's ability to secure future debt financing or attract institutional investors?

What specific milestones or revenue targets must the agriculture segment achieve in the next two quarters to validate the sustainability of this pivot from chemical manufacturing?

Given the drastic increase in stock-in-trade purchases, what are the company's strategies for managing inventory turnover and working capital in its new IT and agriculture service model?

Vellora Impact Rights Committee meets Aug 4 to fix issue price

2 min read     Updated on 30 Jul 2026, 07:07 PM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Vellora Impact Limited schedules its Rights Issue Committee meeting for August 4, 2026, to finalize the price and terms of its ₹70 crore equity raise. The Board had previously approved the issue and an increase in authorized share capital to ₹77.50 crore.

powered bylight_fuzz_icon
46699991

*this image is generated using AI for illustrative purposes only.

Vellora Impact Limited (formerly Pratiksha Chemicals Limited) has scheduled a meeting of its Rights Issue Committee for August 4, 2026, to finalize the issue price and other key terms of its ₹70 crore equity fundraising plan. The committee, comprising Sumit Harjibhai Gol, Kishan Rajeshbhai Mendapara, and Khushbu Hemanshu Nadapara, will determine the entitlement ratio, record date, and payment mechanisms. This development follows the Board’s approval on July 30, 2026, which replaced earlier exploratory discussions with a definitive strategy to raise capital from existing shareholders.

The Board meeting held at the company’s registered office in Ahmedabad also approved an increase in Authorized Share Capital from ₹7.50 crore (75 lakh shares) to ₹77.50 crore (7.75 crore shares). This structural change is necessary to accommodate the issuance of equity shares with a face value of ₹10 each. The proposal requires shareholder approval via Postal Ballot conducted through E-voting. Additionally, the Board rescinded a previous Special Resolution passed on February 20, 2026, regarding authorized capital increase to align with the new rights issue framework.

Rights Issue Parameters

The key details of the proposed fundraising exercise are as follows:

Parameter Detail
Instrument Equity Shares
Face Value ₹10 per share
Maximum Amount ₹70 crore
Issue Type Rights Issue
Eligibility Existing equity shareholders as on record date
Committee Meeting Date August 4, 2026

In compliance with Regulation 29(1)(d) of the SEBI Listing Regulations, the company notified the Bombay Stock Exchange Limited of the committee’s agenda. The committee is authorized to appoint intermediaries and finalize all terms, including the specific issue price, which will be communicated to shareholders after the meeting.

Trading Window Closure

Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company’s Code of Conduct, the trading window for designated persons and their immediate relatives was closed from July 30, 2026. It will remain closed until 48 hours after the conclusion of the Rights Issue Committee meeting on August 4, 2026. This measure ensures compliance with insider trading norms during the sensitive period leading up to the disclosure of material terms.

Promoter Reclassification

Concurrently, the Board approved the reclassification of several entities from the "Promoter and Promoter Group Category" to the "Public Category" under Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This action follows requests dated July 29, 2026, citing the sale of entire shareholdings by most applicants. The reclassification applies to Kantilal Patel, Mukesh Chinubhai Shah, Harish K. Bhatt, Surbhi Harishbhai Bhatt, Harshadbhai K. Patel, Ratnakalaben H. Patel, Jayesh Patel, Purnima Adhvaryu, and Harshad Kantilal Patel HUF. Status updates were also made for Chandraprabha K. Bhatt and Jayesh Bachubhai Chauhan due to their demise, and H B Builders Pvt. Ltd. due to its strike-off from the Register of Companies. These changes are subject to approval from the Bombay Stock Exchange Limited.

What the Numbers Show

The shift from exploring diverse instruments like ADRs, GDRs, and FCCBs to a focused rights issue suggests a preference for diluting ownership among existing stakeholders rather than bringing in new external equity or debt. The substantial increase in authorized capital—from ₹7.50 crore to ₹77.50 crore—indicates that the current ceiling was insufficient not just for the ₹70 crore raise but potentially for future flexibility. The simultaneous reclassification of promoter group members implies a significant reduction in promoter holding concentration, likely enhancing public float and liquidity metrics once the process is complete.

Historical Stock Returns for Pratiksha Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
-3.51%-29.37%-24.68%-33.21%-27.05%+14.75%

How will the reclassification of promoter entities to the public category impact Vellora Impact's public float percentage and potential inclusion in key market indices?

What specific strategic initiatives or debt reduction plans is the company prioritizing with the ₹70 crore raised from the rights issue?

Will the significant increase in authorized capital from ₹7.50 crore to ₹77.50 crore signal intentions for further large-scale fundraising or M&A activities in the near future?

More News on Pratiksha Chemicals

1 Year Returns:-27.05%